Blog
Featured post
Truveta Data now includes more than 120 million de-identified patients
Truveta has also partnered with more than 100 organizations across life sciences, healthcare, public health, academic research organizations, and others to use regulatory-grade EHR data enabling scientifically rigorous research.
Advancing orthopedics: How device-level data is shaping the future of knee, hip, and shoulder replacements
The US market size for joint replacement is projected to balloon to nearly $38 billion by 2030, nearly doubling its 2022 value. The combination of an aging population, increasing...
Truveta recognized on national and Seattle LinkedIn Top Startup 2024 lists
Today, Truveta was featured as #3 on LinkedIn’s inaugural Top Startups in Seattle list. The ranking highlights ten growing start-up companies in the Seattle area. Last month,...
Case study: De-risking clinical development and driving therapeutic innovation in heart failure
Despite advances in guideline-directed medical therapy, heart failure (HF) readmission rates have worsened over the past decade. Optimizing acute inpatient decongestion is...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through August 2024
Overall, the rate of hospitalizations associated with respiratory viruses remained stable throughout August 2024, with no change compared to July 2024. For infants and children...
Top 10 reasons to choose Truveta’s mother-child EHR dataset
Mother and child health are inherently interconnected, offering unique insights into how maternal health, behaviors, and exposures impact child outcomes. Unfortunately, the...
Real-time monitoring of viral gastroenteritis: August 2024
The overall trends of hospitalizations associated with viral gastroenteritis – norovirus and rotavirus – show a steady decrease over the last few months, leading to a rate of...
Truveta and the University of Washington’s CHOICE Institute partner to advance health economics and outcomes research
The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy has partnered with Truveta to use its electronic...
Ensuring privacy and compliance of AI
Continuing with my series on AI, today I want to discuss the following question: How to make healthcare data available for clinical and life science research while leveraging AI...
ISPE 2024: Exploring the impact of removing race as a diagnostic factor for chronic kidney disease: Time to potassium-lowering drugs
Authors: Charlotte Baker DrPH MPH CPH ⊕Truveta, Inc, Bellevue, WA, Brianna M. Goodwin Cartwright ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD MPH ⊕Truveta, Inc,...